200 participants
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-13
- Start Date:
- 2024-09-27
- Completion:
- 2028-03-31
Conditions
- Breast Atypical Ductal Hyperplasia
- Breast Atypical Lobular Hyperplasia
- Breast Carcinoma
- Breast Ductal Carcinoma In Situ
- Breast Lobular Carcinoma In Situ
- Estrogen Receptor-Positive Breast Carcinoma
Interventions
- PROCEDURE
- OTHER
- DRUG
No Results Yet